Details for 2020781202

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATION VON RUXOLITINIB MIT INCB057643 ZUR VERWENDUNG BEI DER BEHANDLUNG VON MYELOPROLIFERATIVEN NEOPLASMEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020781202

EP Publication Number

4161528

E-Number

1853588

Language

PCT Number

US20050753

Publication Date

12.04.2023 A

05.11.2025 B1

Registration Date

05.11.2025

AT Publication Date

15.11.2025

Application Date

14.09.2020

Registration Number

Priorities

03.06.2020

202063034214 P

IPC

A61K 31/538 20060101AFI20211210BHEP

Maximum Duration of Protection

14.09.2040

Owner

Incyte Corporation1801 Augustine Cut-Off Wilmington, DE 19803US

Representative

No representatives present

Inventor

STUBBS, Matthew Wilmington, Delaware 19803US

LIU, Phillip C. Wilmington, Delaware 19803US

Information about Fees